Defence Therapeutics Inc. (DTC)
Market Closed
11 Aug, 20:00
CA$
0. 39
-0.01
-2.5%
CA$
- Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
CA$ 0.4
Previous Close Want to track DTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Defence Therapeutics Inc. (DTC) Statistics
Valuation metrics
Market Cap -
Enterprise value 28.93M
Trailing P/E (ttm) -3.58
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 4.36
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.67K
Average volume (90 days) 38.02K
Price summary
52-Week low 0.37
52-Week high 0.93
Beta -
50-Day moving average 0.43
200-Day moving average 0.53
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.67%
Return on equity -16.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 3.37%
Book value per share (mrq) 0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
